Tag Archives: Warren Woessner

WILL THE NIGHTMARE FOR BIOTECH PREP/PROS NEVER END?

I recently gave a talk on patenting biomarkers, and was asked to talk about “push-back” by the courts and the PTO against getting useful patent claims in this emerging area (the gateway to “personalized medicine.” I was struck with how … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment

BACK TO THE O.K. CORRAL – SHOULD PROFESSORS MANAGE IP LICENSING?

Last summer, Bob Litan and Lesa Mitchell of the Kauffman Foundation sent a short memo to Esther Lee at the Dept. of Commerce entitled “Accelerating the Commercialization of Government-Funded University-Based Research.” Although the Foundation, based in Kansas City MO, has … Continue reading

Posted in Tech Transfer | Tagged , , , , , , , , | 1 Comment

TOP BIOTECH STORIES OF 2009 – DON’T FORGET STEM CELL RESEARCH

The lists of the top pharma/biotech stories for 2009 that I have been seeing online focus mostly on the rise of biosimilars, the spate of mergers and the plurality of Hatch-Waxman litigations that have grabbed the headlines almost daily, along … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , | Leave a comment

Recent EPC rule changes restrict filing of Divisional Applications

Attached is an article by Malcolm Lawrence of HLBBshaw, Epping, UK 1. Background On 25th March 2009, the Administrative Council of the European Patent Organisation issued decision CA/D 2/09 which introduces stricter requirements regarding the filing of divisional applications. These … Continue reading

Posted in EP and UK Practice | Tagged , , , , , | Leave a comment